Journal
EUROPACE
Volume 19, Issue 3, Pages 335-345Publisher
OXFORD UNIV PRESS
DOI: 10.1093/europace/euw180
Keywords
Wearable cardioverter-defibrillator; Sudden cardiac death; Ventricular arrhythmias; External defibrillation; Life vest
Categories
Funding
- ZOLL Medical Corporation
Ask authors/readers for more resources
The wearable cardioverter-defibrillator has been available for over a decade and now is frequently prescribed for patients deemed at high arrhythmic risk in whom the underlying pathology is potentially reversible or who are awaiting an implantable cardioverter-defibrillator. The use of the wearable cardioverter-defibrillator is included in the new 2015 ESC guidelines for the management of ventricular arrhythmias and prevention of sudden cardiac death. The present review provides insight into the current technology and an overview of this approach.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available